Status:
COMPLETED
Cancer Stem Cells in Multiple Myeloma
Lead Sponsor:
Ankara University
Conditions:
Multiple Myeloma
Eligibility:
All Genders
18+ years
Brief Summary
In multiple myeloma "cancer stem" cells can be defined and quantified with flow cytometry. More, these cells can be related to treatment response.
Detailed Description
The investigators' hypothesis is that, multiple myeloma plasma cells derivate from principal cells that is called "cancer or progenitor stem cell". In multiple myeloma to define immunophenotyping feat...
Eligibility Criteria
Inclusion
- New Diagnosed or Relapsed Multiple Myeloma
- Routine Bone Marrow Aspiration will be done
Exclusion
- Bone Marrow Aspiration is not Needed
Key Trial Info
Start Date :
January 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2016
Estimated Enrollment :
96 Patients enrolled
Trial Details
Trial ID
NCT01820546
Start Date
January 1 2013
End Date
January 1 2016
Last Update
January 6 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ankara University Hematology Unit
Ankara, Turkey (Türkiye), 06590